Boston Scientific (BSX) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Boston Scientific (BSX) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.45% |
| Mar 31, 2026 | 32.61% |
| Dec 31, 2025 | 27.94% |
| Sep 30, 2025 | 45.26% |
| Jun 30, 2025 | 48.45% |
| Mar 31, 2025 | 127.75% |
| Dec 31, 2024 | -32.38% |
| Sep 30, 2024 | 30.07% |
| Jun 30, 2024 | 16.04% |
| Mar 31, 2024 | 3.14% |
| Dec 31, 2023 | 5.52% |
| Sep 30, 2023 | 3.17% |
| Jun 30, 2023 | -14.04% |
| Mar 31, 2023 | 0.20% |
| Dec 31, 2022 | 17.14% |
| Sep 30, 2022 | -9.27% |
| Jun 30, 2022 | 11.00% |
| Mar 31, 2022 | -19.67% |
| Dec 31, 2021 | -8.39% |
| Sep 30, 2021 | 12.18% |